TOI partners with Protocol Behavioral Health to integrate mental health services

CERRITOS, Calif. - The Oncology Institute (NASDAQ:TOI), whose stock has surged over 1000% year-to-date according to InvestingPro data, announced Monday a partnership with Protocol Behavioral Health to integrate mental health services into cancer treatment programs.

The collaboration aims to address the psychological challenges faced by cancer patients, with research indicating approximately 30% of cancer patients experience significant depression or anxiety.

Through this partnership, TOI patients will receive mental health services specifically tailored to cancer-related emotional challenges, with no waitlists and full integration into their care teams. Services will be offered in multiple languages to accommodate TOI’s diverse patient population.

"Anxiety and depression can greatly threaten a patient’s outcome by affecting their ability to complete treatment in the recommended time," said Yale Podnos, MD, Chief Medical Officer at The Oncology Institute.

The partnership will implement the Collaborative Care Model (CoCM), an evidence-based framework where Protocol clinicians work directly with TOI providers. Protocol’s behavioral health care managers and psychiatric providers specialize in supporting oncology patients through diagnosis, treatment, and survivorship.

"We founded Protocol to meet a clear need in oncology," said Cara Bohon, PhD, Chief Clinical Officer of Protocol Behavioral Health. "Through this partnership, we’re ensuring that mental health care is not a luxury or an afterthought."

The Oncology Institute, founded in 2007, currently serves approximately 1.9 million patients across five states with over 180 employed and affiliate clinicians and more than 100 clinics and affiliate locations.

The information in this article is based on a company press release statement.

In other recent news, The Oncology Institute reported significant developments impacting its financial performance and operational achievements. The company announced it achieved $1.1 million in Medicare savings through the Centers for Medicare & Medicaid Services’ Enhancing Oncology Model during Performance Period 2. This achievement was accompanied by earning the maximum score on metrics related to avoidable emergency department visits and hospital admissions. In its second quarter financial results, The Oncology Institute posted strong revenue growth that exceeded analyst forecasts. However, the earnings report fell short of analyst expectations, highlighting a mixed financial performance for the period. These recent developments underscore the company’s ongoing efforts to optimize healthcare delivery while managing financial expectations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.